http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009128619-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-28 |
| filingDate | 2008-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009128619-A |
| titleOfInvention | NEW 2-AMINOOXAZOLES AS TAAR1 LIGANDS FOR CNS DISEASES |
| abstract | 1. The use of the compounds of the formula! ! where R1 represents a hydrogen atom, deuterium, tritium, C1-7 alkyl, C1-7 alkoxy, C1-7 alkyl substituted by a halogen atom, C1-7 alkoxy substituted by a halogen atom, a halogen atom, phenyl, possibly substituted a halogen atom, or represents phenyloxy, benzyl, benzyloxy, -COO-C1-7-alkyl, -O- (CH2) o-O-C1-7-alkyl, NH-C3-6-cycloalkyl, C3-6-cycloalkyl or tetrahydropyran-4-yloxy, where for n> 1, these substituents may be the same or different; ! X is a bond, -CHR-, -CHRCHR'-, -OCH2-, -CH2OCHR-, -CH2CH2CH2-, -SCH2-, -S (O) 2CH2-, -CH2SCH2-, -CH2N (R) CH2-, -C3-6-cycloalkyl-CH2- or SiRR'-CH2-, with the exception that when X is —OCH2-, the C1-7 alkoxy group (R1) is not in the 2nd position relative to Y; ! R / R 'independently of each other can represent a hydrogen atom, C1-7-alkyl or C1-7-alkyl substituted by a halogen atom; ! R 2 represents a hydrogen atom, phenyl or C 1-7 alkyl; ! Y represents phenyl, naphthyl, thiophenyl, pyridinyl, C3-6 cycloalkyl, 1,2,3,4-tetrahydro-naphthalen-2-yl, 2,3-dihydrobenzo [1,4] dioxin-6-yl or benzo [1,3] dioxol-5-yl; ! n is 0, 1, 2 or 3; ! o matters 2 or 3:! or a pharmaceutically acceptable acid addition salt in the manufacture of medicaments for the treatment of diseases related to the biological function of trace amine associated receptors, namely anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder, stress disorders, psychotic disorders, schizophrenia, neurological diseases, Parkinson's disease, neurodegenerative disorders, Apzheimer's disease, epilepsy, migraine, substance abuse |
| priorityDate | 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 527.